Aniba riparia (NEES) MEZ, from the Lauraceae family, is popularly named "louro" in Brazil. It belongs to a genus mainly found in Central Amazonia and Guiana comprising approximately 40 species of lowland shrubs and trees. 1, 2) From the green fruit of Aniba riparia, collected from the Amazonas state of Brazil, were isolated three substances with broad spectrum antimicrobial activity: methyl ethers of N-benzoyl tyramine (riparin I), N-(2-hydroxybenzoyl) tyramine (riparin II) and N-(2,6-dihydroxybenzoyl) tyramine (riparin III) 1) which were later synthesized.
From the green fruit of Aniba riparia, collected from the Amazonas state of Brazil, were isolated three substances with broad spectrum antimicrobial activity: methyl ethers of N-benzoyl tyramine (riparin I), N-(2-hydroxybenzoyl) tyramine (riparin II) and N- (2,6-dihydroxybenzoyl) tyramine (riparin III) 1) which were later synthesized.
3)
It was previously reported that (O-methyl)-N-(2,6-dihydroxybenzoyl) tyramine (riparin III) has potent smooth muscle relaxant activity 4, 5) and this spasmolytic effect was possibly related to a reduction of intracellular Ca 2ϩ concentration. 6) Recently, it was reported by us that riparin I 7) and III 8, 9) presented antianxiety effects in mice treated with the doses of 25 and 50 mg/kg. As far as we know, there are no studies in the literature on the central actions of riparin II. However, this substance is an N-(2-hydroxybenzoyl) tyramine, and previous data showed that the spectrum of tyramine actions are similar to those of norepinephrine. In fact, some reports related that tyramine-rich foods when ingested by individuals taking antidepressant drugs, such as monoamino oxidase inhibitors, might result in a prolonged increase in blood pressure. 10) Hereby, these findings led us to investigate the behavioral effects of riparin II on animals models of locomotion, anxiolytic and myorelaxant activities.
MATERIALS AND METHODS

Animals
Male Swiss mice weighing 25-30 g were used in these experiments. The animals were housed in plastic cages, 30 to cage, under a 12 h light/dark cycle (light on at 7:00 a.m.) at constant temperature of 23Ϯ1°C with free access to food and water, except during the experiments. Animals were treated in accordance to the current law and the NIH Guide for Care and Use of Laboratory Animals.
Drugs Riparin II was emulsified with 3% Tween 80 (Sigma-U.S.A.) and dissolved in distilled water. Animals were treated with the compound in doses of 25, 50 and 75 mg/kg, once, 30 or 60 min before the experiments when administered by intraperitoneal or oral routes, respectively. Controls received vehicle at the same volume (10 ml/kg) and the same route as the treated groups. Diazepam (DZP), União Química Brazil, (1, 2 mg/kg) was used as standard.
Experimental Protocol The animals were tested during the light period and were observed in a closed room at constant temperature (23Ϯ1°C) and poorly illuminated with a 15-V red light. One hour after the treatment, the open field and rota rod tests were performed with the same animals in the manner described below: Firstly, the animal was placed in the open field area for 5 min. Immediately after the open field test, the animal was removed to the rota rod where it was evaluated for 1 min. All the other tests were performed in different days with other groups of animals.
Elevated Plus Maze Test (EPM)
The EPM for mice 11) consisted of two opposed open arms (30ϫ5 cm) and two closed arms (30ϫ5ϫ25 cm) also in opposed position. The open and closed arms were connected by a central platform (5ϫ5 cm). The lateral walls of the closed arms were made of transparent acrylic and the floor was made of black acrylic. The maze was 45 cm above the floor. Thirty minutes after intraperitoneal treatment or 60 min after oral treatment, the animal was placed at the center of the plus maze facing one of the enclosed arms, and observed for 5 
Open Field Test
The open field area was made of acrylic (transparent walls and black floor, 30ϫ30ϫ15 cm) divided into nine squares of equal area. The open field was used to evaluate the exploratory activity of the animal.
12) The observed parameters were: number of squares crossed with the four paws (locomotor activity) and numbers of grooming (number of times the animal makes washing movements over the head) and rearing (number of times the animal stood completely erect on its hind legs).
Rota Rod For the rota rod test, the animal was placed with the four paws on a 2.5 cm diameter bar, 25 cm above the floor, which was rotating at 12 rpm. For each animal, the number of falls (up to three falls) and the time of permanence on the bar for 1 min were registered.
13)
Hole Board Test The hole-board test for exploratory behavior of mice was used as described previously by Clark et al. (1971) .
14) The apparatus used was an Ugo Basile of 60 cmϫ30 cm with 16 evenly spaced holes with in built infra red sensors. For each animal, the number of head dips into the holes was counted for each animal for 5 min.
Statistical Analysis All results are presented as meanϮS.E.M. ANOVA followed by Newman-Keuls as the post hoc test was used. Results were considered significant at pϽ0.05.
RESULTS
Figures 2 and 3 show the effects of riparin II from Aniba riparia in EPM test at both routes. The results showed that the oral treatment of riparin II (Fig. 2) In the open field test (Table 1) , the groups treated orally 25 mg/kg and intraperitoneally 75 mg/kg with riparin II decreased the number of rearing as compared to controls. No alteration was observed in the number of crossing and grooming with riparin II at the doses and routes used in the present work. Diazepam (2 mg/kg, i.p.) decreased all the parameters as compared to controls.
In the rota rod test (Table 2) , there were no difference after the treatment with riparin II, at the doses and routes used, unlikely diazepam (2 mg/kg, i.p.) when compared with respective controls. Figure 4 shows 
DISCUSSION
In this work, it was studied the effects in anxiety of riparin II from A. riparia in several behavioral animal models as open field, rota rod, EPM, and hole board tests. These tests are classical models for screening central nervous system actions providing information about psychomotor performance, myorelaxant activity and anxiety.
Behavior in rodents is determined by the conflict between the drive to explore the unknown area/object and the motivation to avoid potential danger. Exploration behavior in rodents summarizes a broad spectrum of behavioral patterns such as risk assessment behaviors, walking, rearing, climbing, sniffing, and manipulating objects. 15) Exploration is gradually inhibited by anxiety, thereby representing an indirect measurement of anxiety. 16, 17) For the EPM test, it has been demonstrated that the preference shown for the closed arms reflects an aversion toward the open arms, caused by fear or anxiety induced by the open space.
18) The EPM test is the most popular test to search for new anxiolytic agents. 17, 19) Thus, the present results show that the riparin II is active in this test of fear or anxiety since riparin II at 25 mg/kg (i.p.) and 75 mg/kg, (p.o.) had anti-anxiety effects, as indicated by increase of the time spent and the number of entries in the open arms. However, even if the doses of 50 mg/kg and 75 mg/kg, i.p., have not presented statistically significant anxiolytic-effect, there was a tendency to have. This fact may not have been detected probably due to the number of animals used, such as the number of animals used in the group of 25 mg/kg was higher than the number used in other groups.
Besides, the anxiolytic-like effect of riparin II was confirmed in the hole board test which measures exploratory behavior. 20) Anxiolytics have been shown to increase the number of head dips.
21) The animals treated with riparin II at both doses (25 and 50 mg/kg, p.o. and i.p.) showed an increase in the number of head dips as the same as diazepam (1 mg/kg), indicating an anti-anxiety activity.
The anxiolytic-like effect of riparin II shown in the plus maze and hole board tests seems to be similar to the riparin III anxiolytic effects. This can be seen comparing riparin II and riparin III. For example, the last substance, when administered intraperitoneally, only presented anxiolytic effect with the higher dose on the plus maze test, but presented anxiolytic effect on the hole board test with both routes and doses used (Sousa et al., 2004) , similarly to riparin II. Besides, the potencies of riparin I, II and III as anxiolytic agents seem to be similar once there are no statistical differences among them. Moreover, none of the three substances seem to present dose-dependency effect, as can be seen in previous works with riparin I (Sousa et al., 2005) and with riparin III (Sousa et al., 2004; Melo et al., 2006) . Similarly, riparin II did not show dose-dependency effect among the treated groups, suggesting that these three substances present similar effects. This can be explained by the similarities between their chemical structures (Fig. 1) .
As riparin II acted similar to DZP in the EPM and hole board tests, it is possible to speculate that its anxiolytic-like effects observed in these tests could be probably related to the potentiation of GABA's inhibitory actions. However, we can not discard that other mechanisms can be involved and further studies need to be performed.
The open-field test is based on rodents' natural tendency to stay near the perimeters of a novel environment (i.e., thigmotaxis), which may serve to protect the animal from avian predators. 22) Anxiolytic effects are indicated by increased entries and time spent in the open-field's central sector, in the absence of concomitant changes in general locomotor activity. 23 ) Previous works showed that drugs which alter locomotor activity may give false-positive/negative results in the plus maze. Therefore, in order to verify the relation between rip II anxiolytic effects with locomotor activity alteration, we used in our protocol the open field test, which also can be useful in detecting genetic or pharmacological effects on anxiety.
23) The open field test, a classical animal model, is used to evaluate autonomic effects of drugs and general activity of animals. 24) Our findings show that the animals treated with riparin II (25, 50, 75 mg/kg) did not alter the locomotor activity, different from diazepam (2 mg/kg) which decreased this parameter showing a sedative effect. In addition, the anxiolytic-like effect of riparin II seems not to be associated with any motor effects since it did not alter significantly the ambulatory behavior in the open field test. This indicates that increased motor activity were not involved in the action seen in both plus maze and hole board tests, and confirms the assumption that the anxiolytic-like effect of riparin II may be specific.
In the rota rod test, different from diazepam (2 mg/kg), riparin II had no effect on the motor co-ordination suggesting that the anxiolytic-like effect of the substance might not be exerted through peripheral neuromuscular blockade, but rather, elicited centrally. 25, 26) In summary, the present data show that riparin II presents anxiolytic-like effects in the EPM and hole board tests, similarly to the other compounds isolated from Aniba riparia, riparin I 7) and III. 8, 9) Moreover, this effect of riparin II was devoid of sedative or myorelaxant effect as assessed by the open field and rota rod tests respectively. 
